chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Moderna Bivalent vaccine have been used to administer a second dose to a patient instead of monovalent; No adverse event; This spontaneous case was reported by a pharmacist and describes the occurrence of WRONG PRODUCT ADMINISTERED (Moderna Bivalent vaccine have been used to administer a second dose to a patient instead of monovalent) and NO ADVERSE EVENT (No adverse event) in a  patient of an unknown age and gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced WRONG PRODUCT ADMINISTERED (Moderna Bivalent vaccine have been used to administer a second dose to a patient instead of monovalent) and NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (Moderna Bivalent vaccine have been used to administer a second dose to a patient instead of monovalent) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (Moderna Bivalent vaccine have been used to administer a second dose to a patient instead of monovalent).    No concomitant medications were reported.  No treatment medications were reported.   Reporter did not allow further contact
erythema 1.5" x 1.0", redened, warm to touch. Used ice & Ibuprofen.
Patient received MMR on 8/19/11, first dose & returned to office on 9/1/11 with rash & again on 9/2/11 as rash seemed worse & confluent. It was red/macular & without any other symptoms.
07MAR95 had temp ranging from 102 to 104; n/v & red pimply rash; seen by MD who suggested may be a react to MMR;
Client was scheduled for second dose of Pfizer on 08/6/21 and per chart review, it was noted that client has already received three Pfizer doses on the following dates: 02/22/21;  03/15/21; 07/09/21.
Fever, chills, severe headache and body aches still happening after 4 days.
Next day post vax, the pt noted pruritis, erythema 10 x 10 cm rash. Seen the following day for fever, chills, nausea, vomiting, and arthralgias.
Extreme vertigo and nausea that lasted 2 weeks without stopping then started fading then week 4 came back just as strong then started coming and going weekly. It is still occurring it feels like when I got post concussion syndrome
chest pain; her lips were swollen/it is on and off; Palpitations off and on; she had a rash on her arms; she had an abnormal feeling in her throat/abnormal feeling in her throat comes and goes, off and on; maybe she is nervous and anxious; maybe she is nervous and anxious; This is a spontaneous report received from a contactable consumer (patient).  A 52-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date unknown), via an unspecified route of administration on the left deltoid, on 19Dec2020, at single dose, for prevention/COVID-19 immunization, at the hospital. Medical history included allergies and allergies to propylene glycol 3350, polysorbate 20, polysulfate 20. It was reported that the patient had a "quick test" and confirmed she has allergies to propylene glycol and polysulfate 20. Her allergist gave her a list of things to stay away from and said to avoid those ingredients. She stated that COVID-19 vaccine has propylene glycol 3350. She clarified and said her allergist told her to stay away from propylene glycol products. Her allergist told her not to use the COVAX. On 19Dec2021, the patient got her first vaccine shot. Within 3 minutes of getting the vaccine, she had rash on her arms. 3 hours later, she had an abnormal feeling in her throat. She was told to go the emergency room and she was given a quick medicine (unspecified). The patient was unable to clarify what medication she received at the emergency room. On 20Dec2021 (the next day), her lips were swollen, on and off. The patient stated she uses dark shampoo and conditioners and maybe it has PEG in it or maybe she is touching something at the hospital. On 20Dec2020, the patient experienced palpitations. She asked the doctors and nurses about her palpitations and they said maybe she was nervous and anxious since she had a COVID patient in the unit. The patient reported that she thinks palpitation started when she went to pick up over the counter medications on 20Dec2020. On 02Jan2021, the patient experienced chest pain. The outcome of rash and palpitations were recovering; oropharyngeal discomfort, lip swelling, and chest pain were not recovered; and nervousness and anxiety were unknown.  Information on the Lot/batch number has been requested.
Rash in the torso, with distinct raised bump/swells. Moderately itchy. Large patches. Red.  Started yesterday morning, more a bother at night than during the day hours. Slight change of smell sensitivity.  Sensation of tight chest, shortness of breath last night during the itchy scratchy episode, only of short duration. Had not reoccurred.  Insomnia last two nights, maybe unrelated, maybe just due to the itches.   Additionally: the injection site was hot and rather painful, for three days only, right after the injection.
I almost immediately began to experience sinusitis issues.  Swelling in face and pain.  I had a voluma injection in April that I had a reaction to.  I have had voluma prior to the vaccine with no adverse effect.  The voluma was removed.  I continued to have sinus symptoms and began to have tingling in my hands and feet.  Reported to primary care.  Stated it was from anxiety and prescribed xanax.  Continued to have worsening sinus symptoms and tingling.  I began having severe pain in both sides of my jaw.  In June I started feeling really bad.   I was flushed and short of breath.  My blood pressure was in critical stroke phase.  I have never had hight blood pressure in my entire life.  My blood pressure was usually on the low side.  I  had ekg's, echocardiograms that were all normal.   ad a CT scan that was normal and then had an MRI of my brain that showed white matter disease.  Saw a neurologist.  She performed an MRI of my back and spine to rule out MS.  It was normal.   She stated the numbness and tingling weren't related to the white matter disease and recommended another MRI one year later. I have had multiple lab tests and they all come back negative.  My symptoms have not subsided at all.  I continue to have unexplained swelling in my neck and face, trouble swallowing, jaw pain, and headaches.  I have developed Raynauds disease and  purpura and have to see a rheumatologist.  I have to see an orthopedic doctor for a nerve test.  I was 100% healthy before I received the vaccine and took 2 medicines.  I now take 2 blood pressure medications and it is still not controlled.  I take cymbalta for anxiety and pain.  I take 2 zyrtec-d a day for sinus relief.  I take 40mg of omeprazole.  10mg ambien, The doctors have tried everything.  I told my primary care I thought this was a reaction to the vaccine and he said it wasn't despite all my ANA, C-reactive protein, and sed rate coming back normal.  I was training for a hike before taking the vaccine and now I barely have the energy to get to work.
Patient was given an adult vaccine Hep A vaccine adult dose given to pediatric patient. Double the dose for age.
pt recvd vax 22JUL93 & had mild cough a/22JUL but no paroxyms; 27JUL had cyanotic episode; seen in ER-no rx; 27JUL MD visit elvated WBC; rx'd w/Albuterol & erythromycin; final dx pertussis;
Patient arrived for COVID-19 vaccine (Moderna vaccine). Patient was underdosed and given 0.05mL, waited for 15 min and then left and no acute reactions were noted. Leadership was notified. Patient was brought back 3 days later for accurate dosing. No adverse event noted
No adverse effects were reported; improperly stored PROQUAD were administered to unspcified patients; This spontaneous report as received from a nurse refers to unspecified patients of unknown age and gender. The patient's pertinent medical history, concurrent conditions and concomitant medications were not reported. On an unknown date the patients were vaccinated with improperly stored with PROQUAD (dosing details were not reported) (lot # M022399, expiry date: 01-NOV-2017) for prophylaxis, which was stored at a temperature of -14.24 °C for 30 minutes (incorrect product storage). No adverse effects were reported. There was no product quality complaint involved. This is one of the two reports received from the same reporter. Additional information is not expected as the reporter did not wish further contact.; Sender's Comments: US-009507513-1612USA007119:
Severe chills around 7 hours after shot for 8 hours. Unbalance for around 12 hours.
Patient called to notify us of a quarter-size round inflamed reaction at the injection site that she discovered this morning. She said she has had soreness since the injection as well.
fever 104.0 all day;1AM 9SEp went to hosp for fever given motrin sent home;9SEP started coughing @ hosp;went to primary MD on 10SEP & was wheezing & coughing recvd albuterol tx in office;wheezed until 3OCT;redness & knots on legs p/vax
symptoms are not going away; arm turning red, still it is red; itching; feeling generally awful; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (arm turning red, still it is red), PRURITUS (itching), DISCOMFORT (feeling generally awful) and GENERAL PHYSICAL CONDITION ABNORMAL (symptoms are not going away) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 028L20A and 028L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 23-Feb-2021, the patient experienced ERYTHEMA (arm turning red, still it is red), PRURITUS (itching) and DISCOMFORT (feeling generally awful). On an unknown date, the patient experienced GENERAL PHYSICAL CONDITION ABNORMAL (symptoms are not going away). At the time of the report, ERYTHEMA (arm turning red, still it is red), PRURITUS (itching), DISCOMFORT (feeling generally awful) and GENERAL PHYSICAL CONDITION ABNORMAL (symptoms are not going away) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant information  provided. Treatment included Benadryl
Extreme swelling, redness of entire deltoid and bicep area to 1/2" above elbow of left arm; Nausea; Fever (100-104.1); Loss of motion; Excessive pain over entire bicep area.
This spontaneous report was received from a nurse refers to multiple unspecified patients of unknown age and gender. Medical history, concurrent conditions and concomitant medications were not reported. On an unknown dates, the patients were vaccinated with improperly stored GARDASIL, lot# K006117, expiry date 14-OCT-2017 and lot# K007264, expiry date 02-MAR-2017. No adverse effects reported. No product quality complaint (PQC) was involved. No further information was provided. This is one of four reports received from the same reporter. Additional information has been requested.
Patient returned 2 days later complaining of fever, injection site pain/swelling, and most concerningly, patient had several small blisters about 6 inches further down arm from the injection site
Mom states pt had vax on Saturday 25JAN92 & on Sunday had hives; hives went away & pt devel welts, on arms & face; acting nl, no fever; eating & playing normally;
Weird bruise on arm for a week after the first shot; This is a spontaneous report from a contactable healthcare professional. A 27-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: ER8737) via an unspecified route of administration in the left arm on 25Mar2021 at 15:30 (at the age of 27-year-old) and second dose of  BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: ER8737) via an unspecified route of administration in the left arm on 21Apr2021 (at the age of 27-year-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included sertraline hydrochloride (ZOLOFT), medroxyprogesterone acetate (DEPO PROVERA), gabapentin (MANUFACTURER UNKNOWN) and oxcarbazepine (MANUFACTURER UNKNOWN); all from unknown dates for unknown indications and unknown if ongoing. The patient had no known allergies. On 25Mar2021 at 15:30, the patient experienced weird bruise on her arm for a week after the first shot. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19.The clinical outcome of the event weird bruise on arm for a week after the first shot was recovered on an unknown date in Apr2021.    No follow-up attempts are needed. No further information is expected.
Patient had an anaphylactic reaction after receving her 4 year old vaccines. She experienced lacrimation, coughing, hives, subcutaneous edema, mild stridor, lip and eye lid swelling. She required oral Benadryl and subcutaneous epinephrine and then was sent to the ER for further observation.
Beginning on December 21, 2021 I began experincing  chronic urticaria and dermatographia.   I had no prior experience of hive in my lifetime with the exception of an isolated incident when I was a preteen .   Blood work was done to rule out any other medical issues and all blood work was normal.    I experience an outbreak 5-7 days a week.    Typically in the evening when my histamine levels are higher and sometimes in the daytime.   The location varies and has been in most parts of my body.    I use antihistimines such as benedryl and calamine spray for relief.
1/19 4:30 PM- extreme body soreness (especially injection site/left arm), headache, chills, and felt like I had a fever (with no fever). 1/19 8:00 PM- Hallucinations began (with eyes closed and open) - started seeing unfamiliar people (faces and outlines), black and white strobing along with seeing pure red light at certain points, I could not control the hallucinations, extreme paranoia (like I was being controlled and watched), physical symptoms magically went away; however, I had pressure in my head that did not hurt like a headache. I was talking to people that were not there. I felt completely out of control. The only thing that helped was forcing myself to focus on the TV, which was extremely difficult. Symptoms started to die down around 3 AM, but did not go away. I slept for 4 hours.  1/20 8 AM- felt like and still feel like I am not in reality, I feel disassociated with my body (like its not mine), slightly out of control of my thoughts, I see subtle black and white flashing like last night but not as intense, paranoia like last night/not as intense, cant concentrate.
This spontaneous report was received from a social media via consumer refers to a female patient (who is the daughter) of unknown age. The medical history, concurrent conditions and concomitant medications were not reported. On an unknown date, the patient was either vaccinated with GARDASIL or GARDASIL 9. On an unknown date, the reporter stated that vaccine hurt his or her daughter. The outcome of the event was unknown. The reporter considered adverse event to be related to GARDASIL 9 or GARDASIL. Additional information is not expected as there was no reporter information.
Patient Covid + on 10/18/2021 at Hospital and vaccinated with Pfizer vaccine with 1st dose on 02/12/2021 and 2nd dose on 03/05/2021.  Per ED Note: This 75-year-old female with history of hypothyroidism and Covid diagnosed 2 weeks ago presents to the emergency department complaint of persistent diarrhea.  Patient states the vomiting has stopped but the diarrhea has persisted loose and watery.  She denies any hematochezia or melena.  Patient states she is currently taking antibiotics started by her PCP for the diarrhea.  She cannot tell me what the name of the antibiotic is.  Patient complains of some shortness of breath but denies any fever.  No prior lung problems.
At approximately 6:47pm, pt w/MOC returned to clinic with concerns that pt "not responding". Noted unresponsive to touch stimuli, bluing around lips. Pulse ox at 82%, O2 via mask placed at 100%, 911 dispatched, assessed by doctor. At approximately 6:51pm pt pink, crying, PO at 98%, HR 150's.
Pt recv vax on 3/9/99; on 3/10/99 pt exp erythematous, pruritic, macular rash over body x 48 hr; tx=Benadryl & Prednisone
About 10 cm erythema and warmth in are where shots received (right thigh). Localized skin reaction. Pt c/o itching. Treatment: diphenhydramine 12.5/5ml; 5 ml PO q 6 hrs PRN for itching. Hydrocortisone 1 % cream; apply BID PRN for itching.
pt recv vax & w/in 24hr pt devel an inj site edema, h/a & diff focusing eyes;pt has recovered;
Really large hard red welts, purple centers. Described by physician as "unusual" lasted 5 days. This was the 4th dose in a series of 5. No previous problems at all.
I21.4 ACUTE NON ST ELEVATION MI 8/1/2023 INCARCERATED HIATAL HERNIA I21.4 ACUTE NON ST ELEVATION MI 8/1/2023 CKD STAGE 4 (GFR 15-29) I21.4 ACUTE NON ST ELEVATION MI 8/1/2023 ACUTE NON ST ELEVATION MI
Skin is red, tender, and warm to the touch at the injection site; Skin is red, tender, and warm to the touch at the injection site; Skin is red, tender, and warm to the touch at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (Skin is red, tender, and warm to the touch at the injection site), VACCINATION SITE PAIN (Skin is red, tender, and warm to the touch at the injection site) and VACCINATION SITE WARMTH (Skin is red, tender, and warm to the touch at the injection site) in a 27-year-old male patient who received mRNA-1273.815 (SPIKEVAX 2023-2024) for COVID-19 prophylaxis.     The patient's past medical history included COVID-19 (Patient was diagnosed with Covid 19) in 2022.    On 30-Sep-2023, the patient received dose of mRNA-1273.815 (SPIKEVAX 2023-2024) (Intramuscular use) 1 dosage form. In 2023, the patient experienced VACCINATION SITE ERYTHEMA (Skin is red, tender, and warm to the touch at the injection site), VACCINATION SITE PAIN (Skin is red, tender, and warm to the touch at the injection site) and VACCINATION SITE WARMTH (Skin is red, tender, and warm to the touch at the injection site). At the time of the report, VACCINATION SITE ERYTHEMA (Skin is red, tender, and warm to the touch at the injection site), VACCINATION SITE PAIN (Skin is red, tender, and warm to the touch at the injection site) and VACCINATION SITE WARMTH (Skin is red, tender, and warm to the touch at the injection site) outcome was unknown.        The action taken with mRNA-1273.815 (SPIKEVAX 2023-2024) (Intramuscular use) was unknown.       Patient skin was red, tender, and warm to the touch at the injection site and was Painful to the touch.  It was unknown if the patient had experienced any additional symptoms/events.  The patient had no medical history, concomitant disease or risk factor. Concomitant medications were not reported.  No treatment information was provided by the reporter.
Information has been received from a physician concerning a patient who was vaccinated with a dose of VARIVAX (lot# 661008/1317X). Concomitant therapy included MMR II (lot # 660275/1255X). Patient experienced injection site swelling. The patient sought unspecified medical attention. Follow up information received on 03-FEB-2009 stated that a phone call was received from the medical assistant, he stated that there was no record of the patient, the patient was not documented and no further information was available. This is one of 2 reports from the same source. Additional information has been requested.
PATIENT HAD 3 EVENINGS OF CHILLS. AREA WHERE SHE GOT THE SHOT FELT HOT TO TOUCH. THERE WAS ALSO A RASH IN THE AREA THAT RESOLVED SLOWLY OVER A 3 WEEK PERIOD.
Pt was unable to get out of bed within 12 hours, and needed assistance to use the restroom until her death
Day 1 - injection site pain and swelling. Duration 15 mins. Day 2 - body ache mainly located in neck and shoulders. Treated with ibuprofen and rest Day 3 - body ache. Treated with ibuprofen Day 4- body ache Day 5- severe vertigo and dizziness. Treated with meclizine, Phenergan Day 6- vertigo,  dizziness, and headache . Treated with meclizine and aspirin  Day 7- vertigo, dizziness.  Treated with meclizine  Day 8- vertigo, dizziness. Treated with meclizine  Day 9- vertigo,  dizziness. Treated with meclizine and Valium Day 10- vertigo,  dizziness,  headache. Treated with meclizine
semi paralized; This spontaneous case was reported by a consumer and describes the occurrence of PARESIS (semi paralized) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PARESIS (semi paralized) (seriousness criterion hospitalization prolonged). At the time of the report, PARESIS (semi paralized) outcome was unknown.            Concomitant product use was not provided by the reporter. Treatment information was not provided.  Very limited information regarding this event has been provided at this time. Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded. Further information has been requested.; Sender's Comments: Very limited information regarding this event has been provided at this time. Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded. Further information has been requested.
Patient contacted the administering pharmacist after receiving her vaccine.  She reported that her arm became red, swollen and warm the evening after receiving the flu vaccine. She also developed hives.  She presented to a nurse (patient is a teacher and presented to the school nurse) who told her it was likely she was experiencing an allergic reaction to the vaccine.  Patient was able to return to work normally the next day. Patient had received the same vaccine last year with no allergic reaction and has no history of allergy to any previous vaccine.